<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01511250</url>
  </required_header>
  <id_info>
    <org_study_id>INV-DEN-203</org_study_id>
    <nct_id>NCT01511250</nct_id>
  </id_info>
  <brief_title>Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years</brief_title>
  <official_title>A Double-Blind, Randomized, Placebo-Controlled, Age Descending and Expansion Phase 2 Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety of Takeda's tetravalent dengue vaccine
      (TDV) (previously DENVax) administered subcutaneously in healthy adults and children. In
      addition the antibody response to the four dengue virus serotypes will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The vaccine tested in this study was tetravalent dengue vaccine (TDV). TDV was tested to
      assess safety and immunogenicity in healthy adults and children living in dengue endemic
      countries.

      The study enrolled 360 healthy participants. The study was conducted in 2 parts, Part 1 - age
      descending and and Part 2 - expansion - ages 1.5-11 years. Participants were allocated to one
      of the four age cohorts in Part 1 (21 to 45 years, 12 to 20 years, 6 to 11 years, and 1.5 to
      5 years) and expansion age cohort 1.5-11 years in Part 2. Participants were randomized in 2:1
      ratio and in 3: 1 ratio in Part 1 and 2 respectively to receive:

        -  TDV 0.5 mL SC injection

        -  Placebo (inactive solution) - this is a solution that looks like the study drug but has
           no active ingredient

      This multi-center trial was conducted worldwide. The overall time to participate in this
      study was up to 37 months (including screening period). Participants made multiple visits to
      the clinic including a final visit at Day 1080.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 16, 2011</start_date>
  <completion_date type="Actual">April 15, 2016</completion_date>
  <primary_completion_date type="Actual">April 1, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (Diary-Recorded) Following Either Vaccination Dose by Severity</measure>
    <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
    <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (In Clinic Assessment) Following Either Vaccination Dose by Severity</measure>
    <time_frame>Within 28 days after either of the vaccination given on Day 0 or 90 (Day 28 for first vaccination, Day 118 for second vaccination)</time_frame>
    <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Systemic Adverse Events (AEs) (Diary-Recorded) Following Either Vaccination Dose by Severity</measure>
    <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
    <description>Solicited systemic AEs (headache, muscle pain [myalgia], joint pain [arthralgia], eye pain, sensitivity to light [photophobia], tiredness [fatigue], body rash, nausea, were recorded in the participant's-diary along with vomiting [number of times]), and body temperature). Diary-recorded severity grades were based on the Common Terminology Criteria for Adverse Events (CTCAE). Severity grades were: Mild (Grade 1): transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): marked symptoms, moderate interference with participant's daily activities. Severe (Grade 3): Considerable interference with participant's daily activities. The CTCAE severity grades for fever and vomiting were derived from the diary-recorded measurements of temperature level and number of episodes, respectively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Any Solicited AE Following Either Vaccination Dose</measure>
    <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. Solicited local injection site reactions included pain, itching, erythema, edema and solicited systemic AEs include myalgia, arthralgia, eye pain, photophobia, fatigue, body rash, nausea, vomiting, and fever.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With at Least One Unsolicited AE Following Either Vaccination Dose by Severity</measure>
    <time_frame>Unsolicited AEs were collected within 28 days of all vaccinations. Serious AEs were collected throughout the study up to Day 1080</time_frame>
    <description>An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. The severity of all unsolicited AEs was evaluated by the Investigator (using the Common Terminology Criteria for Adverse Events [CTCAE] v4.03) as follows. Mild (Grade 1): Transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): Marked symptoms, moderate interference with participant's daily activities. Severe (Grade 3): Considerable interference with participant's daily activities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seropositivity Rate to Each of the Four Dengue Serotypes at Day 120</measure>
    <time_frame>30 days after second vaccination (Day 120)</time_frame>
    <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 for any serotype and seronegative was defined as titre value of less than (&lt;) 10 for all 4 serotypes. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Part I: Number of Participants Positive for Vaccine Viremia for Each of Four Vaccine Strain Serotypes After the Each Vaccination</measure>
    <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
    <description>Vaccine viremia was assessed for each of the four vaccine strain serotypes: TDV-1, TDV-2, TDV-3 and TDV-4 for Part-1. Vaccine viral ribonucleic acid (RNA) was detected by a quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part I: Duration of Vaccine Viremia</measure>
    <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part I: Titers of Vaccine Viremia</measure>
    <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seropositivity Rate to Each of the Four Dengue Serotypes</measure>
    <time_frame>Day 28 and Day 90 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
    <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 and seronegative was defined as titre value of less than (&lt;) 10. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seroconversion Rate to Each of the Four Dengue Serotypes</measure>
    <time_frame>Day 28, 90 and 120 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
    <description>Seroconversion rate was defined as the percentage of participants with microneutralization test 50% (MNT50) titer â‰¥10 or, if the titer on Day 0 was â‰¥10, a 4-fold rise in antibody titer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Neutralizing Antibody Titers (GMTs) of All Four Dengue Serotypes</measure>
    <time_frame>Day 28, 90 and 120 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
    <description>GMTs were assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, and TDV-4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Fold Rise (GMFR) of Dengue Neutralizing Antibody Titers for Each of the 4 Dengue Serotypes</measure>
    <time_frame>Day 28 and Day 90 (Parts 1 and 2) and Days 120, 180, 360, 720 and 1080 in Part 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Confirmed Dengue Fever</measure>
    <time_frame>Day 1 to Day 1080</time_frame>
    <description>Dengue fever was assessed in participants who had 3 consecutive days of fever &gt;38Â°C and tested positive for dengue virus by polymerase chain reaction (PCR) analysis.</description>
  </secondary_outcome>
  <number_of_arms>10</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Part I: TDV 21 to 45 Years (yrs)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: Placebo 21 to 45 yrs</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: TDV 12 to 20 yrs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: Placebo 12 to 20 yrs</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: TDV 6 to 11 yrs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: Placebo 6 to 11 yrs</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: TDV 1.5 to 5 yrs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part I: Placebo 1.5 to 5 yrs</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part II: TDV 1.5 to 11 yrs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part II: Placebo 1.5 to 11 yrs</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>TDV</intervention_name>
    <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose). TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
    <arm_group_label>Part I: TDV 21 to 45 Years (yrs)</arm_group_label>
    <arm_group_label>Part I: TDV 12 to 20 yrs</arm_group_label>
    <arm_group_label>Part I: TDV 6 to 11 yrs</arm_group_label>
    <arm_group_label>Part I: TDV 1.5 to 5 yrs</arm_group_label>
    <arm_group_label>Part II: TDV 1.5 to 11 yrs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose).</description>
    <arm_group_label>Part I: Placebo 21 to 45 yrs</arm_group_label>
    <arm_group_label>Part I: Placebo 12 to 20 yrs</arm_group_label>
    <arm_group_label>Part I: Placebo 6 to 11 yrs</arm_group_label>
    <arm_group_label>Part I: Placebo 1.5 to 5 yrs</arm_group_label>
    <arm_group_label>Part II: Placebo 1.5 to 11 yrs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In good health as determined by medical history, physical examination including height
             and weight

          -  Normal safety laboratory values at screening

          -  Negative for human immunodeficiency virus-1 (HIV-1) antibodies, Hepatitis C antibodies
             &amp; Hepatitis B surface antigen

          -  Females negative by urine pregnancy test at screening and immediately prior to
             injection, and were willing to use reliable means of contraception

          -  Weight: Within 1.3 times of the upper limit of local normal age-adjusted body mass
             index (BMI)

        Exclusion Criteria:

          -  For participants â‰¥12 years, clinically significant electrocardiogram (ECG) findings

          -  History of significant dermatologic (skin) disease within last 6 months

          -  History of diabetes mellitus

          -  History of thymic pathology, thymectomy, myasthenia or any immunodeficiency

          -  History of recurring headaches or migraines

          -  Hypersensitivity to any vaccine

          -  For participants â‰¥12 years, positive urine screen for cocaine, amphetamines, opiates,
             or cannabinoids

          -  History of alcohol abuse

          -  Pregnant or lactating female
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director Clinical Science</last_name>
    <role>Study Director</role>
    <affiliation>Takeda</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Program For The Study and Control of Tropical Diseases</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ponce School of Medicine, CAIMED Center</name>
      <address>
        <city>Ponce</city>
        <zip>716</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Puerto Rico School of Medicine</name>
      <address>
        <city>San Juan</city>
        <zip>00935</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Latin Clinical Trial Center</name>
      <address>
        <city>San Juan</city>
        <zip>909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculty of Tropical Medicine, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
    <country>Puerto Rico</country>
    <country>Singapore</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>January 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2012</study_first_posted>
  <results_first_submitted>November 20, 2017</results_first_submitted>
  <results_first_submitted_qc>February 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 27, 2018</results_first_posted>
  <disposition_first_submitted>November 29, 2016</disposition_first_submitted>
  <disposition_first_submitted_qc>November 29, 2016</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">November 30, 2016</disposition_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Normal healthy adults and children</keyword>
  <keyword>Safety and tolerability</keyword>
  <keyword>Active vaccine</keyword>
  <keyword>Placebo</keyword>
  <keyword>Dengue virus vaccine</keyword>
  <keyword>Immune response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at 8 investigative sites in Puerto Rico, Colombia, Singapore and Thailand from 16 November 2011 to 15 April 2016.</recruitment_details>
      <pre_assignment_details>Healthy participants were enrolled in the 2-part study to receive 0.5 mL tetravalent dengue vaccine (TDV) or placebo in 1 of 4 groups for Part I: 21-45 years, 12-20 years, 6-11 years, 1.5-5 years, and in 1 group for Part II: 1.5-11 years. Part II started after all subjects in Part 1 were enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Part I: TDV 21 to 45 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="P2">
          <title>Part I: Placebo 21 to 45 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
        </group>
        <group group_id="P3">
          <title>Part I: TDV 12 to 20 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="P4">
          <title>Part I: Placebo 12 to 20 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
        </group>
        <group group_id="P5">
          <title>Part I: TDV 6 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="P6">
          <title>Part I: Placebo 6 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
        </group>
        <group group_id="P7">
          <title>Part I: TDV 1.5 to 5 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="P8">
          <title>Part I: Placebo 1.5 to 5 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
        <group group_id="P9">
          <title>Part II: TDV 1.5 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="P10">
          <title>Part II: Placebo 1.5 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="21"/>
                <participants group_id="P6" count="17"/>
                <participants group_id="P7" count="23"/>
                <participants group_id="P8" count="13"/>
                <participants group_id="P9" count="159"/>
                <participants group_id="P10" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="18"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="21"/>
                <participants group_id="P6" count="17"/>
                <participants group_id="P7" count="21"/>
                <participants group_id="P8" count="9"/>
                <participants group_id="P9" count="145"/>
                <participants group_id="P10" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="14"/>
                <participants group_id="P10" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal of Consent</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor/Investigator Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="13"/>
                <participants group_id="P10" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The full analysis set (FAS) included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
      <group_list>
        <group group_id="B1">
          <title>Part I: TDV 21 to 45 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="B2">
          <title>Part I: Placebo 21 to 45 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
        </group>
        <group group_id="B3">
          <title>Part I: TDV 12 to 20 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="B4">
          <title>Part I: Placebo 12 to 20 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
        </group>
        <group group_id="B5">
          <title>Part I: TDV 6 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="B6">
          <title>Part I: Placebo 6 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
        </group>
        <group group_id="B7">
          <title>Part I: TDV 1.5 to 5 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="B8">
          <title>Part I: Placebo 1.5 to 5 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
        <group group_id="B9">
          <title>Part II: TDV 1.5 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="B10">
          <title>Part II: Placebo 1.5 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
        <group group_id="B11">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="22"/>
            <count group_id="B4" value="14"/>
            <count group_id="B5" value="21"/>
            <count group_id="B6" value="17"/>
            <count group_id="B7" value="23"/>
            <count group_id="B8" value="13"/>
            <count group_id="B9" value="159"/>
            <count group_id="B10" value="53"/>
            <count group_id="B11" value="360"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.2" lower_limit="21.0" upper_limit="45.0"/>
                    <measurement group_id="B2" value="30.1" lower_limit="21.0" upper_limit="40.0"/>
                    <measurement group_id="B3" value="15.5" lower_limit="12.0" upper_limit="19.0"/>
                    <measurement group_id="B4" value="16.8" lower_limit="12.0" upper_limit="20.0"/>
                    <measurement group_id="B5" value="8.4" lower_limit="6.0" upper_limit="11.0"/>
                    <measurement group_id="B6" value="7.8" lower_limit="6.0" upper_limit="11.0"/>
                    <measurement group_id="B7" value="3.3" lower_limit="1.5" upper_limit="5.0"/>
                    <measurement group_id="B8" value="3.5" lower_limit="2.3" upper_limit="5.0"/>
                    <measurement group_id="B9" value="6.6" lower_limit="1.6" upper_limit="11.0"/>
                    <measurement group_id="B10" value="6.8" lower_limit="2.1" upper_limit="11.0"/>
                    <measurement group_id="B11" value="9.8" lower_limit="1.5" upper_limit="45.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="8"/>
                    <measurement group_id="B7" value="7"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="88"/>
                    <measurement group_id="B10" value="19"/>
                    <measurement group_id="B11" value="172"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="16"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="71"/>
                    <measurement group_id="B10" value="34"/>
                    <measurement group_id="B11" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="12"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="77"/>
                    <measurement group_id="B10" value="24"/>
                    <measurement group_id="B11" value="177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="11"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="79"/>
                    <measurement group_id="B10" value="27"/>
                    <measurement group_id="B11" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Seropositive to any Serotype at Day 0</title>
          <description>Seropositivity is defined as a reciprocal neutralizing titer measured by a microneutralizing test 50% (MNT50) greater or equal to (â‰¥)10.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Seropositive to any Serotype=No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="14"/>
                    <measurement group_id="B7" value="16"/>
                    <measurement group_id="B8" value="12"/>
                    <measurement group_id="B9" value="93"/>
                    <measurement group_id="B10" value="24"/>
                    <measurement group_id="B11" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seropositive to any Serotype=Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="7"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="66"/>
                    <measurement group_id="B10" value="29"/>
                    <measurement group_id="B11" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>meters (m)</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.68" lower_limit="1.57" upper_limit="1.82"/>
                    <measurement group_id="B2" value="1.65" lower_limit="1.53" upper_limit="1.87"/>
                    <measurement group_id="B3" value="1.58" lower_limit="1.38" upper_limit="1.72"/>
                    <measurement group_id="B4" value="1.60" lower_limit="1.41" upper_limit="1.73"/>
                    <measurement group_id="B5" value="1.29" lower_limit="1.08" upper_limit="1.52"/>
                    <measurement group_id="B6" value="1.27" lower_limit="1.13" upper_limit="1.42"/>
                    <measurement group_id="B7" value="0.98" lower_limit="0.83" upper_limit="1.13"/>
                    <measurement group_id="B8" value="0.99" lower_limit="0.90" upper_limit="1.06"/>
                    <measurement group_id="B9" value="1.20" lower_limit="0.77" upper_limit="1.62"/>
                    <measurement group_id="B10" value="1.22" lower_limit="0.83" upper_limit="1.63"/>
                    <measurement group_id="B11" value="1.28" lower_limit="0.77" upper_limit="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms (kg)</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.6" lower_limit="41.4" upper_limit="115.1"/>
                    <measurement group_id="B2" value="80.2" lower_limit="56.3" upper_limit="120.4"/>
                    <measurement group_id="B3" value="57.0" lower_limit="28.6" upper_limit="93.4"/>
                    <measurement group_id="B4" value="59.5" lower_limit="48.6" upper_limit="89.9"/>
                    <measurement group_id="B5" value="31.2" lower_limit="18.5" upper_limit="51.2"/>
                    <measurement group_id="B6" value="27.0" lower_limit="20.3" upper_limit="37.5"/>
                    <measurement group_id="B7" value="15.1" lower_limit="10.3" upper_limit="22.2"/>
                    <measurement group_id="B8" value="16.5" lower_limit="13.3" upper_limit="20.8"/>
                    <measurement group_id="B9" value="25.7" lower_limit="10.4" upper_limit="61.0"/>
                    <measurement group_id="B10" value="26.7" lower_limit="10.6" upper_limit="53.2"/>
                    <measurement group_id="B11" value="34.3" lower_limit="10.3" upper_limit="120.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.81" lower_limit="14.70" upper_limit="41.30"/>
                    <measurement group_id="B2" value="29.05" lower_limit="21.30" upper_limit="38.70"/>
                    <measurement group_id="B3" value="22.60" lower_limit="15.00" upper_limit="33.60"/>
                    <measurement group_id="B4" value="23.09" lower_limit="18.60" upper_limit="31.50"/>
                    <measurement group_id="B5" value="18.38" lower_limit="12.90" upper_limit="28.80"/>
                    <measurement group_id="B6" value="16.56" lower_limit="14.20" upper_limit="20.60"/>
                    <measurement group_id="B7" value="15.63" lower_limit="12.50" upper_limit="19.00"/>
                    <measurement group_id="B8" value="16.95" lower_limit="13.20" upper_limit="20.40"/>
                    <measurement group_id="B9" value="17.02" lower_limit="12.10" upper_limit="30.10"/>
                    <measurement group_id="B10" value="17.08" lower_limit="13.20" upper_limit="24.30"/>
                    <measurement group_id="B11" value="18.83" lower_limit="12.10" upper_limit="41.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (Diary-Recorded) Following Either Vaccination Dose by Severity</title>
        <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
        <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (Diary-Recorded) Following Either Vaccination Dose by Severity</title>
          <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="56"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="41"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="11"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="26"/>
                    <measurement group_id="O10" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="19"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="24"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="21"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="13"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="9"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (In Clinic Assessment) Following Either Vaccination Dose by Severity</title>
        <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
        <time_frame>Within 28 days after either of the vaccination given on Day 0 or 90 (Day 28 for first vaccination, Day 118 for second vaccination)</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Local (Injection Site) Adverse Events (AEs) (In Clinic Assessment) Following Either Vaccination Dose by Severity</title>
          <description>Solicited local injection site reactions were collected by subject diary and graded based on the Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03 for pain [Grade 0 (no pain), 1 (mild), 2 (moderate) and 3 (severe)] and itching (pruritus) [Grade 0 (no itching), 1 (mild), 2 (moderate) and 3 (Severe]. Severity grade for redness (erythema) and swelling (edema/induration) were derived from recorded length of the longest diameter measurement using the FDA Guidance for Industry: Toxicity Grading Scale of Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trial were Grade 0 (&lt;2.5 cm), 1 (mild: 2.5-5 cm), 2 (moderate: 5.1-10 cm) and 3 (severe: &gt;10 cm) and Grade 4 (Potentially Life-threatening: necrosis or exfoliative dermatitis).</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="33"/>
                    <measurement group_id="O10" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="28"/>
                    <measurement group_id="O10" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Systemic Adverse Events (AEs) (Diaryâ€“Recorded) Following Either Vaccination Dose by Severity</title>
        <description>Solicited systemic AEs (headache, muscle pain [myalgia], joint pain [arthralgia], eye pain, sensitivity to light [photophobia], tiredness [fatigue], body rash, nausea, were recorded in the participantâ€™s-diary along with vomiting [number of times]), and body temperature). Diary-recorded severity grades were based on the Common Terminology Criteria for Adverse Events (CTCAE). Severity grades were: Mild (Grade 1): transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): marked symptoms, moderate interference with participantâ€™s daily activities. Severe (Grade 3): Considerable interference with participantâ€™s daily activities. The CTCAE severity grades for fever and vomiting were derived from the diary-recorded measurements of temperature level and number of episodes, respectively.</description>
        <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Systemic Adverse Events (AEs) (Diaryâ€“Recorded) Following Either Vaccination Dose by Severity</title>
          <description>Solicited systemic AEs (headache, muscle pain [myalgia], joint pain [arthralgia], eye pain, sensitivity to light [photophobia], tiredness [fatigue], body rash, nausea, were recorded in the participantâ€™s-diary along with vomiting [number of times]), and body temperature). Diary-recorded severity grades were based on the Common Terminology Criteria for Adverse Events (CTCAE). Severity grades were: Mild (Grade 1): transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): marked symptoms, moderate interference with participantâ€™s daily activities. Severe (Grade 3): Considerable interference with participantâ€™s daily activities. The CTCAE severity grades for fever and vomiting were derived from the diary-recorded measurements of temperature level and number of episodes, respectively.</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo). Only categories for which there was at least 1 participant are reported.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="33"/>
                    <measurement group_id="O10" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="27"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache, Any Grade</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="46"/>
                    <measurement group_id="O10" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="30"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="30"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="21"/>
                    <measurement group_id="O10" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="10"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="7"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye Pain, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="14"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye Pain, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="11"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye Pain, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye Pain, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photophobia, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="11"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photophobia, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="9"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photophobia, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photophobia, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="29"/>
                    <measurement group_id="O10" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="19"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="7"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body rash, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="14"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body rash, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body rash, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body rash, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="22"/>
                    <measurement group_id="O10" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="14"/>
                    <measurement group_id="O10" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting, Any Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="18"/>
                    <measurement group_id="O10" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting, Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting, Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="11"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting, Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Any Solicited AE Following Either Vaccination Dose</title>
        <description>An AE is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. Solicited local injection site reactions included pain, itching, erythema, edema and solicited systemic AEs include myalgia, arthralgia, eye pain, photophobia, fatigue, body rash, nausea, vomiting, and fever.</description>
        <time_frame>Within 14 days after either of the vaccination given on Day 0 or 90 (Day 14 for first vaccination, Day 104 for second vaccination)</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Any Solicited AE Following Either Vaccination Dose</title>
          <description>An AE is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. Solicited local injection site reactions included pain, itching, erythema, edema and solicited systemic AEs include myalgia, arthralgia, eye pain, photophobia, fatigue, body rash, nausea, vomiting, and fever.</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="110"/>
                    <measurement group_id="O10" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With at Least One Unsolicited AE Following Either Vaccination Dose by Severity</title>
        <description>An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. The severity of all unsolicited AEs was evaluated by the Investigator (using the Common Terminology Criteria for Adverse Events [CTCAE] v4.03) as follows. Mild (Grade 1): Transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): Marked symptoms, moderate interference with participant's daily activities. Severe (Grade 3): Considerable interference with participant's daily activities.</description>
        <time_frame>Unsolicited AEs were collected within 28 days of all vaccinations. Serious AEs were collected throughout the study up to Day 1080</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With at Least One Unsolicited AE Following Either Vaccination Dose by Severity</title>
          <description>An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. The severity of all unsolicited AEs was evaluated by the Investigator (using the Common Terminology Criteria for Adverse Events [CTCAE] v4.03) as follows. Mild (Grade 1): Transient symptoms, discomfort noticed but was easily tolerated by the participant with no interference to normal daily activities. Moderate (Grade 2): Marked symptoms, moderate interference with participant's daily activities. Severe (Grade 3): Considerable interference with participant's daily activities.</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At least one unsolicited AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="12"/>
                    <measurement group_id="O9" value="101"/>
                    <measurement group_id="O10" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsolicited AEs by worst severity, Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="72"/>
                    <measurement group_id="O10" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsolicited AEs by worst severity, Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="25"/>
                    <measurement group_id="O10" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsolicited AEs by worst severity, Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Seropositivity Rate to Each of the Four Dengue Serotypes at Day 120</title>
        <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 for any serotype and seronegative was defined as titre value of less than (&lt;) 10 for all 4 serotypes. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
        <time_frame>30 days after second vaccination (Day 120)</time_frame>
        <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample has been received.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Seropositivity Rate to Each of the Four Dengue Serotypes at Day 120</title>
          <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 for any serotype and seronegative was defined as titre value of less than (&lt;) 10 for all 4 serotypes. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
          <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample has been received.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="22"/>
                <count group_id="O8" value="11"/>
                <count group_id="O9" value="156"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O2" value="92.3" lower_limit="64" upper_limit="99.8"/>
                    <measurement group_id="O3" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="100.0" lower_limit="97.7" upper_limit="100.0"/>
                    <measurement group_id="O10" value="43.4" lower_limit="29.8" upper_limit="57.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O2" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O3" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="100.0" lower_limit="97.7" upper_limit="100.0"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="75.3" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="29.4" lower_limit="10.3" upper_limit="56"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="99.4" lower_limit="96.5" upper_limit="100.0"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O2" value="61.5" lower_limit="31.6" upper_limit="86.1"/>
                    <measurement group_id="O3" value="72.7" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O4" value="71.4" lower_limit="41.9" upper_limit="91.6"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="29.4" lower_limit="10.3" upper_limit="56.0"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="94.9" lower_limit="90.1" upper_limit="97.8"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part I: Number of Participants Positive for Vaccine Viremia for Each of Four Vaccine Strain Serotypes After the Each Vaccination</title>
        <description>Vaccine viremia was assessed for each of the four vaccine strain serotypes: TDV-1, TDV-2, TDV-3 and TDV-4 for Part-1. Vaccine viral ribonucleic acid (RNA) was detected by a quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay.</description>
        <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
        <population>The FAS included all randomized participants who received at least one dose of study vaccine and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Part I: Number of Participants Positive for Vaccine Viremia for Each of Four Vaccine Strain Serotypes After the Each Vaccination</title>
          <description>Vaccine viremia was assessed for each of the four vaccine strain serotypes: TDV-1, TDV-2, TDV-3 and TDV-4 for Part-1. Vaccine viral ribonucleic acid (RNA) was detected by a quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay.</description>
          <population>The FAS included all randomized participants who received at least one dose of study vaccine and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 0, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 0, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 0, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 97, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 97, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 97, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 97, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 104, TDV-1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 104, TDV-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 104, TDV-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 104, TDV-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part I: Duration of Vaccine Viremia</title>
        <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
        <population>Due to the very low prevalence of vaccine viremia, there was insufficient data for the estimation of average titer duration of viral RNA within study groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Part I: Duration of Vaccine Viremia</title>
          <population>Due to the very low prevalence of vaccine viremia, there was insufficient data for the estimation of average titer duration of viral RNA within study groups.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part I: Titers of Vaccine Viremia</title>
        <time_frame>Days 0, 7, 14, 90, 97, and 104</time_frame>
        <population>Due to the very low prevalence of vaccine viremia, there was insufficient data for the estimation of average titer duration of viral RNA within study groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Part I: Titers of Vaccine Viremia</title>
          <population>Due to the very low prevalence of vaccine viremia, there was insufficient data for the estimation of average titer duration of viral RNA within study groups.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Seropositivity Rate to Each of the Four Dengue Serotypes</title>
        <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 and seronegative was defined as titre value of less than (&lt;) 10. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
        <time_frame>Day 28 and Day 90 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
        <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Seropositivity Rate to Each of the Four Dengue Serotypes</title>
          <description>Seropositivity rate, defined as the percentage of participants seropositive, was derived from titers of dengue-neutralizing antibodies. Participants were classified by titer after Day 0 as seropositive or seronegative. Seropositive was defined as a MNT50 titre value of â‰¥10 and seronegative was defined as titre value of less than (&lt;) 10. Seropositivity was assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, TDV-4.</description>
          <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O2" value="92.3" lower_limit="64.0" upper_limit="99.8"/>
                    <measurement group_id="O3" value="86.4" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O8" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O9" value="100.0" lower_limit="97.7" upper_limit="100.0"/>
                    <measurement group_id="O10" value="41.5" lower_limit="28.1" upper_limit="55.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.8" upper_limit="100.0"/>
                    <measurement group_id="O2" value="92.3" lower_limit="64.0" upper_limit="99.8"/>
                    <measurement group_id="O3" value="86.4" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="95.7" lower_limit="78.1" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="96.8" lower_limit="92.8" upper_limit="99.0"/>
                    <measurement group_id="O10" value="34.0" lower_limit="21.5" upper_limit="48.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" lower_limit="78.9" upper_limit="99.9"/>
                    <measurement group_id="O2" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O3" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O4" value="92.9" lower_limit="66.1" upper_limit="99.8"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="91.3" lower_limit="72.0" upper_limit="98.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="95.6" lower_limit="91.1" upper_limit="98.2"/>
                    <measurement group_id="O10" value="39.6" lower_limit="26.5" upper_limit="54.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.2" lower_limit="57.8" upper_limit="92.9"/>
                    <measurement group_id="O2" value="76.9" lower_limit="46.2" upper_limit="95.0"/>
                    <measurement group_id="O3" value="59.1" lower_limit="36.4" upper_limit="79.2"/>
                    <measurement group_id="O4" value="78.6" lower_limit="49.2" upper_limit="95.3"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="69.6" lower_limit="47.1" upper_limit="86.8"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="74.1" lower_limit="66.5" upper_limit="80.7"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="92.3" lower_limit="64.0" upper_limit="99.8"/>
                    <measurement group_id="O3" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="99.4" lower_limit="96.5" upper_limit="100.0"/>
                    <measurement group_id="O10" value="41.5" lower_limit="28.1" upper_limit="55.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="85.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O3" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="98.7" lower_limit="95.5" upper_limit="99.8"/>
                    <measurement group_id="O10" value="34.0" lower_limit="21.5" upper_limit="48.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="78.1" upper_limit="99.9"/>
                    <measurement group_id="O2" value="100.0" lower_limit="75.3" upper_limit="100.0"/>
                    <measurement group_id="O3" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100" lower_limit="83.9" upper_limit="100"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="81.8" lower_limit="59.7" upper_limit="94.8"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O9" value="89.9" lower_limit="84.2" upper_limit="94.1"/>
                    <measurement group_id="O10" value="34.0" lower_limit="21.5" upper_limit="48.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.6" lower_limit="61.2" upper_limit="95.0"/>
                    <measurement group_id="O2" value="69.2" lower_limit="38.6" upper_limit="90.9"/>
                    <measurement group_id="O3" value="77.3" lower_limit="54.6" upper_limit="92.2"/>
                    <measurement group_id="O4" value="78.6" lower_limit="49.2" upper_limit="95.3"/>
                    <measurement group_id="O5" value="66.7" lower_limit="43.0" upper_limit="85.4"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O9" value="69.8" lower_limit="62.0" upper_limit="76.8"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="83.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="91.7" lower_limit="61.5" upper_limit="99.8"/>
                    <measurement group_id="O3" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="83.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="83.3" lower_limit="51.6" upper_limit="97.9"/>
                    <measurement group_id="O3" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="83.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="91.7" lower_limit="61.5" upper_limit="99.8"/>
                    <measurement group_id="O3" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O4" value="85.7" lower_limit="57.2" upper_limit="98.2"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="35.3" lower_limit="14.2" upper_limit="61.7"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.0" lower_limit="68.3" upper_limit="98.8"/>
                    <measurement group_id="O2" value="66.7" lower_limit="34.9" upper_limit="90.1"/>
                    <measurement group_id="O3" value="76.2" lower_limit="52.8" upper_limit="91.8"/>
                    <measurement group_id="O4" value="78.6" lower_limit="49.2" upper_limit="95.3"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="77.3" lower_limit="54.6" upper_limit="92.2"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="82.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="91.7" lower_limit="61.5" upper_limit="99.8"/>
                    <measurement group_id="O3" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="29.4" lower_limit="10.3" upper_limit="56.0"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="82.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="83.3" lower_limit="51.6" upper_limit="97.9"/>
                    <measurement group_id="O3" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="29.4" lower_limit="10.3" upper_limit="56.0"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.5" lower_limit="66.9" upper_limit="98.7"/>
                    <measurement group_id="O2" value="83.3" lower_limit="51.6" upper_limit="97.9"/>
                    <measurement group_id="O3" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="29.4" lower_limit="10.3" upper_limit="56.0"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.2" lower_limit="60.4" upper_limit="96.6"/>
                    <measurement group_id="O2" value="75.0" lower_limit="42.8" upper_limit="94.5"/>
                    <measurement group_id="O3" value="66.7" lower_limit="43.0" upper_limit="85.4"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="79.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O3" value="89.5" lower_limit="66.9" upper_limit="98.7"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="79.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O3" value="94.7" lower_limit="74.0" upper_limit="99.9"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="84.6" upper_limit="100.0"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" lower_limit="61.7" upper_limit="98.4"/>
                    <measurement group_id="O2" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O3" value="68.4" lower_limit="43.4" upper_limit="87.4"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="71.4" lower_limit="47.8" upper_limit="88.7"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.3" lower_limit="54.4" upper_limit="96.0"/>
                    <measurement group_id="O2" value="77.8" lower_limit="40.0" upper_limit="97.2"/>
                    <measurement group_id="O3" value="63.2" lower_limit="38.4" upper_limit="83.7"/>
                    <measurement group_id="O4" value="84.6" lower_limit="54.6" upper_limit="98.1"/>
                    <measurement group_id="O5" value="57.1" lower_limit="34.0" upper_limit="78.2"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="72.7" lower_limit="49.8" upper_limit="89.3"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="78.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="63.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="94.4" lower_limit="72.7" upper_limit="99.9"/>
                    <measurement group_id="O4" value="81.8" lower_limit="48.2" upper_limit="97.7"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="78.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="100.0" lower_limit="81.5" upper_limit="100.0"/>
                    <measurement group_id="O4" value="81.8" lower_limit="48.2" upper_limit="97.7"/>
                    <measurement group_id="O5" value="100.0" lower_limit="83.9" upper_limit="100.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3" lower_limit="68.1" upper_limit="99.8"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="77.8" lower_limit="52.4" upper_limit="93.6"/>
                    <measurement group_id="O4" value="81.8" lower_limit="48.2" upper_limit="97.7"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.0" lower_limit="51.9" upper_limit="95.7"/>
                    <measurement group_id="O2" value="87.5" lower_limit="47.3" upper_limit="99.7"/>
                    <measurement group_id="O3" value="61.1" lower_limit="35.7" upper_limit="82.7"/>
                    <measurement group_id="O4" value="72.7" lower_limit="39.0" upper_limit="94.0"/>
                    <measurement group_id="O5" value="42.9" lower_limit="21.8" upper_limit="66.0"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="47.6" lower_limit="25.7" upper_limit="70.2"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Seroconversion Rate to Each of the Four Dengue Serotypes</title>
        <description>Seroconversion rate was defined as the percentage of participants with microneutralization test 50% (MNT50) titer â‰¥10 or, if the titer on Day 0 was â‰¥10, a 4-fold rise in antibody titer.</description>
        <time_frame>Day 28, 90 and 120 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
        <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Seroconversion Rate to Each of the Four Dengue Serotypes</title>
          <description>Seroconversion rate was defined as the percentage of participants with microneutralization test 50% (MNT50) titer â‰¥10 or, if the titer on Day 0 was â‰¥10, a 4-fold rise in antibody titer.</description>
          <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.8" lower_limit="25.6" upper_limit="67.2"/>
                    <measurement group_id="O2" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O3" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="23.2"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="87.0" lower_limit="66.4" upper_limit="97.2"/>
                    <measurement group_id="O8" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O9" value="86.1" lower_limit="79.7" upper_limit="91.1"/>
                    <measurement group_id="O10" value="1.9" lower_limit="0.0" upper_limit="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="15.6" upper_limit="55.3"/>
                    <measurement group_id="O2" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O3" value="59.1" lower_limit="36.4" upper_limit="79.3"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="23.2"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="87.0" lower_limit="66.4" upper_limit="97.2"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="86.7" lower_limit="80.4" upper_limit="91.6"/>
                    <measurement group_id="O10" value="0.0" lower_limit="0.0" upper_limit="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="15.6" upper_limit="55.3"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O3" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.0" upper_limit="19.5"/>
                    <measurement group_id="O7" value="78.3" lower_limit="56.3" upper_limit="92.5"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="82.3" lower_limit="75.4" upper_limit="87.9"/>
                    <measurement group_id="O10" value="1.9" lower_limit="0.0" upper_limit="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.8" lower_limit="7.1" upper_limit="42.2"/>
                    <measurement group_id="O2" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O3" value="31.8" lower_limit="13.9" upper_limit="54.9"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="23.2"/>
                    <measurement group_id="O5" value="71.4" lower_limit="47.8" upper_limit="88.7"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="60.9" lower_limit="38.5" upper_limit="80.3"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O9" value="62.7" lower_limit="54.6" upper_limit="70.2"/>
                    <measurement group_id="O10" value="5.7" lower_limit="1.2" upper_limit="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.1" lower_limit="19.7" upper_limit="61.5"/>
                    <measurement group_id="O2" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O3" value="54.5" lower_limit="32.2" upper_limit="75.6"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.0" upper_limit="19.5"/>
                    <measurement group_id="O7" value="81.8" lower_limit="59.7" upper_limit="94.8"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="82.4" lower_limit="75.6" upper_limit="88.0"/>
                    <measurement group_id="O10" value="3.8" lower_limit="0.5" upper_limit="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.4" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O2" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O3" value="59.1" lower_limit="36.4" upper_limit="79.3"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.0" upper_limit="19.5"/>
                    <measurement group_id="O7" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="86.2" lower_limit="79.8" upper_limit="91.1"/>
                    <measurement group_id="O10" value="1.9" lower_limit="0.0" upper_limit="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.4" lower_limit="13.2" upper_limit="52.9"/>
                    <measurement group_id="O2" value="23.1" lower_limit="5.0" upper_limit="53.8"/>
                    <measurement group_id="O3" value="59.1" lower_limit="36.4" upper_limit="79.3"/>
                    <measurement group_id="O4" value="14.3" lower_limit="1.8" upper_limit="42.8"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.0" upper_limit="19.5"/>
                    <measurement group_id="O7" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O9" value="76.1" lower_limit="68.7" upper_limit="82.5"/>
                    <measurement group_id="O10" value="0.0" lower_limit="0.0" upper_limit="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" lower_limit="7.5" upper_limit="43.7"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O3" value="50.0" lower_limit="28.2" upper_limit="71.8"/>
                    <measurement group_id="O4" value="21.4" lower_limit="4.7" upper_limit="50.8"/>
                    <measurement group_id="O5" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="54.5" lower_limit="32.2" upper_limit="75.6"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O9" value="57.9" lower_limit="49.8" upper_limit="65.6"/>
                    <measurement group_id="O10" value="5.7" lower_limit="1.2" upper_limit="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O3" value="68.2" lower_limit="45.1" upper_limit="86.1"/>
                    <measurement group_id="O4" value="14.3" lower_limit="1.8" upper_limit="42.8"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="88.5" lower_limit="82.4" upper_limit="93.0"/>
                    <measurement group_id="O10" value="3.8" lower_limit="0.5" upper_limit="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="24.7"/>
                    <measurement group_id="O3" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="23.2"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="90.4" lower_limit="84.6" upper_limit="94.5"/>
                    <measurement group_id="O10" value="3.8" lower_limit="0.5" upper_limit="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O2" value="30.8" lower_limit="9.1" upper_limit="61.4"/>
                    <measurement group_id="O3" value="68.2" lower_limit="45.1" upper_limit="86.1"/>
                    <measurement group_id="O4" value="14.3" lower_limit="1.8" upper_limit="42.8"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="86.5" lower_limit="80.2" upper_limit="91.5"/>
                    <measurement group_id="O10" value="1.9" lower_limit="0.0" upper_limit="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.9" lower_limit="20.7" upper_limit="63.6"/>
                    <measurement group_id="O2" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O3" value="45.5" lower_limit="24.4" upper_limit="67.8"/>
                    <measurement group_id="O4" value="14.3" lower_limit="1.8" upper_limit="42.8"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="23.5" lower_limit="6.8" upper_limit="49.9"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O9" value="84.0" lower_limit="77.3" upper_limit="89.4"/>
                    <measurement group_id="O10" value="3.8" lower_limit="0.5" upper_limit="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="27.2" upper_limit="72.8"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="23.2"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="90.9" lower_limit="70.8" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.0" lower_limit="36.1" upper_limit="80.9"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.0" lower_limit="19.1" upper_limit="63.9"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.5" upper_limit="98.8"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="86.4" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.0" lower_limit="23.1" upper_limit="68.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="47.6" lower_limit="25.7" upper_limit="70.2"/>
                    <measurement group_id="O4" value="7.1" lower_limit="0.2" upper_limit="33.9"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="72.7" lower_limit="49.8" upper_limit="98.3"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.6" lower_limit="28.9" upper_limit="75.6"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="57.1" lower_limit="34.0" upper_limit="78.2"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="90.9" lower_limit="70.8" upper_limit="98.9"/>
                    <measurement group_id="O8" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.4" lower_limit="24.4" upper_limit="71.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="61.9" lower_limit="38.4" upper_limit="81.9"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="76.2" lower_limit="52.8" upper_limit="91.8"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.8" lower_limit="16.3" upper_limit="61.6"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="57.1" lower_limit="34.0" upper_limit="78.2"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="76.2" lower_limit="52.8" upper_limit="91.8"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="81.8" lower_limit="59.7" upper_limit="94.8"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1" lower_limit="20.3" upper_limit="66.5"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="38.1" lower_limit="18.1" upper_limit="61.6"/>
                    <measurement group_id="O4" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O5" value="57.1" lower_limit="34.0" upper_limit="78.2"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="59.1" lower_limit="36.4" upper_limit="79.3"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="24.7" upper_limit="75.3"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O3" value="47.4" lower_limit="24.4" upper_limit="71.1"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="95.2" lower_limit="76.2" upper_limit="99.9"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="86.4" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="24.7" upper_limit="75.3"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O3" value="57.9" lower_limit="33.5" upper_limit="79.7"/>
                    <measurement group_id="O4" value="7.7" lower_limit="0.2" upper_limit="36.0"/>
                    <measurement group_id="O5" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="95.5" lower_limit="77.2" upper_limit="99.9"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.8" lower_limit="19.8" upper_limit="70.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                    <measurement group_id="O3" value="31.6" lower_limit="12.6" upper_limit="56.6"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="66.7" lower_limit="43.0" upper_limit="85.4"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="86.4" lower_limit="65.1" upper_limit="97.1"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" lower_limit="4.0" upper_limit="45.6"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O3" value="36.8" lower_limit="16.3" upper_limit="61.6"/>
                    <measurement group_id="O4" value="15.4" lower_limit="1.9" upper_limit="45.4"/>
                    <measurement group_id="O5" value="47.6" lower_limit="25.7" upper_limit="70.2"/>
                    <measurement group_id="O6" value="17.6" lower_limit="3.8" upper_limit="43.4"/>
                    <measurement group_id="O7" value="63.6" lower_limit="40.7" upper_limit="82.8"/>
                    <measurement group_id="O8" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.7" lower_limit="21.3" upper_limit="73.4"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O3" value="55.6" lower_limit="30.8" upper_limit="78.5"/>
                    <measurement group_id="O4" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O5" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.7" lower_limit="21.3" upper_limit="73.4"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O3" value="61.1" lower_limit="35.7" upper_limit="82.7"/>
                    <measurement group_id="O4" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="85.7" lower_limit="63.7" upper_limit="97.0"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="33.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="11.8" upper_limit="61.6"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="36.9"/>
                    <measurement group_id="O3" value="44.4" lower_limit="21.5" upper_limit="69.2"/>
                    <measurement group_id="O4" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O5" value="81.0" lower_limit="58.1" upper_limit="94.6"/>
                    <measurement group_id="O6" value="5.9" lower_limit="0.1" upper_limit="28.7"/>
                    <measurement group_id="O7" value="90.5" lower_limit="69.6" upper_limit="98.8"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="1.7" upper_limit="40.5"/>
                    <measurement group_id="O2" value="12.5" lower_limit="0.3" upper_limit="52.7"/>
                    <measurement group_id="O3" value="27.8" lower_limit="9.7" upper_limit="53.5"/>
                    <measurement group_id="O4" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O5" value="33.3" lower_limit="14.6" upper_limit="57.0"/>
                    <measurement group_id="O6" value="11.8" lower_limit="1.5" upper_limit="36.4"/>
                    <measurement group_id="O7" value="38.1" lower_limit="18.1" upper_limit="61.6"/>
                    <measurement group_id="O8" value="11.1" lower_limit="0.3" upper_limit="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Neutralizing Antibody Titers (GMTs) of All Four Dengue Serotypes</title>
        <description>GMTs were assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, and TDV-4.</description>
        <time_frame>Day 28, 90 and 120 (Parts 1 and 2) and Days 180, 360, 720 and 1080 in Part 1</time_frame>
        <population>The FAS included all randomized participants who received at least one dose of study vaccine and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received. Here &quot;n&quot; is the number of participants with microneutralizing (MN) assay samples.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Neutralizing Antibody Titers (GMTs) of All Four Dengue Serotypes</title>
          <description>GMTs were assessed for the four dengue serotypes: TDV-1, TDV-2, TDV-3, and TDV-4.</description>
          <population>The FAS included all randomized participants who received at least one dose of study vaccine and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received. Here &quot;n&quot; is the number of participants with microneutralizing (MN) assay samples.</population>
          <units>titer</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1156.9" lower_limit="582.0" upper_limit="2299.9"/>
                    <measurement group_id="O2" value="396.1" lower_limit="120.6" upper_limit="1301.2"/>
                    <measurement group_id="O3" value="919.5" lower_limit="273.1" upper_limit="3096.1"/>
                    <measurement group_id="O4" value="204.9" lower_limit="59.8" upper_limit="702.6"/>
                    <measurement group_id="O5" value="383.7" lower_limit="178.1" upper_limit="826.5"/>
                    <measurement group_id="O6" value="11.3" lower_limit="4.4" upper_limit="29.3"/>
                    <measurement group_id="O7" value="395.2" lower_limit="190.0" upper_limit="822.0"/>
                    <measurement group_id="O8" value="5.3" lower_limit="4.7" upper_limit="5.9"/>
                    <measurement group_id="O9" value="522.2" lower_limit="396.5" upper_limit="687.7"/>
                    <measurement group_id="O10" value="28.7" lower_limit="14.8" upper_limit="55.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2313.9" lower_limit="1328.1" upper_limit="4031.2"/>
                    <measurement group_id="O2" value="178.0" lower_limit="44.4" upper_limit="712.9"/>
                    <measurement group_id="O3" value="1726.6" lower_limit="539.2" upper_limit="5528.8"/>
                    <measurement group_id="O4" value="420.2" lower_limit="116.5" upper_limit="1515.6"/>
                    <measurement group_id="O5" value="2357.2" lower_limit="1218.6" upper_limit="4559.7"/>
                    <measurement group_id="O6" value="13.9" lower_limit="5.0" upper_limit="38.6"/>
                    <measurement group_id="O7" value="1134.6" lower_limit="479.9" upper_limit="2682.6"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the lower limit of detection (LLOD).</measurement>
                    <measurement group_id="O9" value="1496.5" lower_limit="1129.1" upper_limit="1983.4"/>
                    <measurement group_id="O10" value="16.4" lower_limit="9.7" upper_limit="27.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="538.2" lower_limit="218.3" upper_limit="1326.5"/>
                    <measurement group_id="O2" value="226.3" lower_limit="70.1" upper_limit="730.7"/>
                    <measurement group_id="O3" value="330.2" lower_limit="94.4" upper_limit="1155.9"/>
                    <measurement group_id="O4" value="304.5" lower_limit="83.9" upper_limit="1105.6"/>
                    <measurement group_id="O5" value="314.8" lower_limit="135.3" upper_limit="732.3"/>
                    <measurement group_id="O6" value="8.5" lower_limit="4.1" upper_limit="17.4"/>
                    <measurement group_id="O7" value="129.6" lower_limit="52.9" upper_limit="317.6"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="206.9" lower_limit="149.9" upper_limit="285.7"/>
                    <measurement group_id="O10" value="19.4" lower_limit="11.5" upper_limit="32.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.7" lower_limit="54.3" upper_limit="314.5"/>
                    <measurement group_id="O2" value="55.1" lower_limit="15.6" upper_limit="194.9"/>
                    <measurement group_id="O3" value="56.6" lower_limit="19.1" upper_limit="167.3"/>
                    <measurement group_id="O4" value="46.4" lower_limit="17.6" upper_limit="122.4"/>
                    <measurement group_id="O5" value="61.4" lower_limit="27.1" upper_limit="139.4"/>
                    <measurement group_id="O6" value="7.2" lower_limit="3.9" upper_limit="13.4"/>
                    <measurement group_id="O7" value="27.0" lower_limit="12.5" upper_limit="58.5"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="45.4" lower_limit="33.2" upper_limit="62.0"/>
                    <measurement group_id="O10" value="11.0" lower_limit="7.8" upper_limit="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="961.3" lower_limit="413.5" upper_limit="2235.2"/>
                    <measurement group_id="O2" value="751.0" lower_limit="227.1" upper_limit="2483.1"/>
                    <measurement group_id="O3" value="555.4" lower_limit="156.9" upper_limit="1966.2"/>
                    <measurement group_id="O4" value="215.3" lower_limit="55.4" upper_limit="836.4"/>
                    <measurement group_id="O5" value="245.7" lower_limit="82.2" upper_limit="734.7"/>
                    <measurement group_id="O6" value="10.8" lower_limit="4.2" upper_limit="28.3"/>
                    <measurement group_id="O7" value="165.1" lower_limit="69.4" upper_limit="392.8"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="324.2" lower_limit="239.1" upper_limit="439.6"/>
                    <measurement group_id="O10" value="27.9" lower_limit="14.6" upper_limit="53.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2073.1" lower_limit="1267.0" upper_limit="3392.1"/>
                    <measurement group_id="O2" value="320.0" lower_limit="74.2" upper_limit="1379.3"/>
                    <measurement group_id="O3" value="1146.4" lower_limit="416.7" upper_limit="3153.6"/>
                    <measurement group_id="O4" value="463.9" lower_limit="120.1" upper_limit="1792.0"/>
                    <measurement group_id="O5" value="966.9" lower_limit="451.8" upper_limit="2069.2"/>
                    <measurement group_id="O6" value="10.0" lower_limit="4.3" upper_limit="23.1"/>
                    <measurement group_id="O7" value="467.0" lower_limit="205.7" upper_limit="1060.3"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="463.5" lower_limit="364.0" upper_limit="590.2"/>
                    <measurement group_id="O10" value="15.2" lower_limit="8.9" upper_limit="25.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="510.5" lower_limit="218.3" upper_limit="1194.1"/>
                    <measurement group_id="O2" value="272.7" lower_limit="86.4" upper_limit="860.4"/>
                    <measurement group_id="O3" value="193.3" lower_limit="54.9" upper_limit="680.7"/>
                    <measurement group_id="O4" value="336.2" lower_limit="95.3" upper_limit="1185.8"/>
                    <measurement group_id="O5" value="195.0" lower_limit="73.3" upper_limit="518.8"/>
                    <measurement group_id="O6" value="8.5" lower_limit="4.4" upper_limit="16.5"/>
                    <measurement group_id="O7" value="66.2" lower_limit="28.3" upper_limit="154.8"/>
                    <measurement group_id="O8" value="5.3" lower_limit="4.6" upper_limit="6.1"/>
                    <measurement group_id="O9" value="139.5" lower_limit="99.7" upper_limit="195.1"/>
                    <measurement group_id="O10" value="17.1" lower_limit="10.2" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125.7" lower_limit="57.7" upper_limit="274.1"/>
                    <measurement group_id="O2" value="36.0" lower_limit="13.3" upper_limit="97.2"/>
                    <measurement group_id="O3" value="76.3" lower_limit="29.3" upper_limit="198.9"/>
                    <measurement group_id="O4" value="69.0" lower_limit="23.7" upper_limit="200.4"/>
                    <measurement group_id="O5" value="31.2" lower_limit="12.3" upper_limit="79.3"/>
                    <measurement group_id="O6" value="7.5" lower_limit="4.0" upper_limit="14.3"/>
                    <measurement group_id="O7" value="16.8" lower_limit="9.3" upper_limit="30.5"/>
                    <measurement group_id="O8" value="5.3" lower_limit="4.6" upper_limit="6.1"/>
                    <measurement group_id="O9" value="33.7" lower_limit="25.4" upper_limit="44.7"/>
                    <measurement group_id="O10" value="11.8" lower_limit="8.2" upper_limit="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1240.3" lower_limit="585.2" upper_limit="2628.8"/>
                    <measurement group_id="O2" value="356.0" lower_limit="117.8" upper_limit="1076.1"/>
                    <measurement group_id="O3" value="1300.3" lower_limit="528.5" upper_limit="3199.4"/>
                    <measurement group_id="O4" value="164.0" lower_limit="52.8" upper_limit="509.4"/>
                    <measurement group_id="O5" value="551.7" lower_limit="231.6" upper_limit="1313.8"/>
                    <measurement group_id="O6" value="13.9" lower_limit="4.9" upper_limit="39.2"/>
                    <measurement group_id="O7" value="582.3" lower_limit="275.9" upper_limit="1229.1"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="710.4" lower_limit="547.5" upper_limit="921.9"/>
                    <measurement group_id="O10" value="29.6" lower_limit="15.6" upper_limit="56.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2403.7" lower_limit="1443.5" upper_limit="4002.6"/>
                    <measurement group_id="O2" value="272.7" lower_limit="60.9" upper_limit="1221.6"/>
                    <measurement group_id="O3" value="1754.0" lower_limit="744.2" upper_limit="4134.4"/>
                    <measurement group_id="O4" value="399.9" lower_limit="109.7" upper_limit="1457.7"/>
                    <measurement group_id="O5" value="983.0" lower_limit="423.5" upper_limit="2281.6"/>
                    <measurement group_id="O6" value="17.3" lower_limit="4.6" upper_limit="65.9"/>
                    <measurement group_id="O7" value="459.7" lower_limit="232.6" upper_limit="908.7"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="605.4" lower_limit="490.6" upper_limit="747.1"/>
                    <measurement group_id="O10" value="16.2" lower_limit="9.5" upper_limit="27.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="650.2" lower_limit="288.1" upper_limit="1467.0"/>
                    <measurement group_id="O2" value="287.6" lower_limit="116.7" upper_limit="709.1"/>
                    <measurement group_id="O3" value="340.8" lower_limit="121.3" upper_limit="957.6"/>
                    <measurement group_id="O4" value="289.8" lower_limit="82.7" upper_limit="1016.1"/>
                    <measurement group_id="O5" value="377.4" lower_limit="170.3" upper_limit="836.6"/>
                    <measurement group_id="O6" value="14.4" lower_limit="5.0" upper_limit="41.8"/>
                    <measurement group_id="O7" value="196.4" lower_limit="115.2" upper_limit="334.8"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="332.3" lower_limit="263.1" upper_limit="419.7"/>
                    <measurement group_id="O10" value="19.0" lower_limit="11.3" upper_limit="32.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="193.3" lower_limit="84.7" upper_limit="441.1"/>
                    <measurement group_id="O2" value="36.0" lower_limit="10.5" upper_limit="123.2"/>
                    <measurement group_id="O3" value="82.6" lower_limit="31.8" upper_limit="214.1"/>
                    <measurement group_id="O4" value="69.0" lower_limit="23.5" upper_limit="202.7"/>
                    <measurement group_id="O5" value="64.6" lower_limit="27.6" upper_limit="151.1"/>
                    <measurement group_id="O6" value="13.9" lower_limit="5.4" upper_limit="35.3"/>
                    <measurement group_id="O7" value="41.3" lower_limit="24.9" upper_limit="68.3"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="76.5" lower_limit="60.5" upper_limit="96.8"/>
                    <measurement group_id="O10" value="11.2" lower_limit="8.0" upper_limit="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="831.7" lower_limit="332.7" upper_limit="2078.8"/>
                    <measurement group_id="O2" value="320.0" lower_limit="86.0" upper_limit="1191.4"/>
                    <measurement group_id="O3" value="954.7" lower_limit="280.8" upper_limit="3245.7"/>
                    <measurement group_id="O4" value="141.6" lower_limit="38.8" upper_limit="516.4"/>
                    <measurement group_id="O5" value="230.5" lower_limit="107.2" upper_limit="495.4"/>
                    <measurement group_id="O6" value="12.8" lower_limit="4.7" upper_limit="34.4"/>
                    <measurement group_id="O7" value="249.2" lower_limit="113.5" upper_limit="546.8"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2521.2" lower_limit="1444.5" upper_limit="4400.4"/>
                    <measurement group_id="O2" value="226.3" lower_limit="48.9" upper_limit="1046.4"/>
                    <measurement group_id="O3" value="1515.6" lower_limit="593.7" upper_limit="3869.0"/>
                    <measurement group_id="O4" value="412.3" lower_limit="104.9" upper_limit="1620.6"/>
                    <measurement group_id="O5" value="642.5" lower_limit="325.9" upper_limit="1266.8"/>
                    <measurement group_id="O6" value="14.4" lower_limit="4.9" upper_limit="42.4"/>
                    <measurement group_id="O7" value="399.3" lower_limit="194.7" upper_limit="819.1"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="422.2" lower_limit="179.1" upper_limit="995.5"/>
                    <measurement group_id="O2" value="285.1" lower_limit="74.7" upper_limit="1087.6"/>
                    <measurement group_id="O3" value="321.2" lower_limit="101.3" upper_limit="1018.4"/>
                    <measurement group_id="O4" value="206.1" lower_limit="65.9" upper_limit="645.0"/>
                    <measurement group_id="O5" value="189.1" lower_limit="84.2" upper_limit="424.6"/>
                    <measurement group_id="O6" value="12.5" lower_limit="5.5" upper_limit="28.4"/>
                    <measurement group_id="O7" value="93.6" lower_limit="41.4" upper_limit="211.7"/>
                    <measurement group_id="O8" value="6.0" lower_limit="4.0" upper_limit="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146.7" lower_limit="62.8" upper_limit="342.7"/>
                    <measurement group_id="O2" value="44.9" lower_limit="13.0" upper_limit="155.7"/>
                    <measurement group_id="O3" value="71.5" lower_limit="27.6" upper_limit="185.0"/>
                    <measurement group_id="O4" value="51.2" lower_limit="19.8" upper_limit="132.4"/>
                    <measurement group_id="O5" value="47.2" lower_limit="20.4" upper_limit="109.3"/>
                    <measurement group_id="O6" value="9.2" lower_limit="4.4" upper_limit="19.4"/>
                    <measurement group_id="O7" value="28.3" lower_limit="14.3" upper_limit="56.0"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1417.4" lower_limit="474.5" upper_limit="4233.5"/>
                    <measurement group_id="O2" value="320.0" lower_limit="78.5" upper_limit="1304.5"/>
                    <measurement group_id="O3" value="642.5" lower_limit="179.5" upper_limit="2299.8"/>
                    <measurement group_id="O4" value="221.0" lower_limit="48.9" upper_limit="999.6"/>
                    <measurement group_id="O5" value="132.0" lower_limit="51.6" upper_limit="338.0"/>
                    <measurement group_id="O6" value="15.7" lower_limit="5.5" upper_limit="45.2"/>
                    <measurement group_id="O7" value="220.9" lower_limit="90.3" upper_limit="540.2"/>
                    <measurement group_id="O8" value="5.3" lower_limit="4.6" upper_limit="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2410.7" lower_limit="1120.9" upper_limit="5185.0"/>
                    <measurement group_id="O2" value="271.8" lower_limit="60.9" upper_limit="1212.7"/>
                    <measurement group_id="O3" value="852.2" lower_limit="369.9" upper_limit="1963.3"/>
                    <measurement group_id="O4" value="523.6" lower_limit="113.4" upper_limit="2416.7"/>
                    <measurement group_id="O5" value="329.5" lower_limit="161.7" upper_limit="671.1"/>
                    <measurement group_id="O6" value="17.1" lower_limit="6.0" upper_limit="48.7"/>
                    <measurement group_id="O7" value="298.8" lower_limit="141.1" upper_limit="632.8"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="537.9" lower_limit="158.5" upper_limit="1825.3"/>
                    <measurement group_id="O2" value="256.2" lower_limit="70.2" upper_limit="935.3"/>
                    <measurement group_id="O3" value="171.3" lower_limit="51.1" upper_limit="574.0"/>
                    <measurement group_id="O4" value="209.5" lower_limit="55.4" upper_limit="792.9"/>
                    <measurement group_id="O5" value="103.1" lower_limit="40.0" upper_limit="265.6"/>
                    <measurement group_id="O6" value="11.8" lower_limit="5.3" upper_limit="26.0"/>
                    <measurement group_id="O7" value="89.9" lower_limit="43.9" upper_limit="184.1"/>
                    <measurement group_id="O8" value="5">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163.6" lower_limit="56.2" upper_limit="476.4"/>
                    <measurement group_id="O2" value="44.9" lower_limit="13.5" upper_limit="149.1"/>
                    <measurement group_id="O3" value="73.8" lower_limit="26.9" upper_limit="202.8"/>
                    <measurement group_id="O4" value="59.9" lower_limit="19.4" upper_limit="184.4"/>
                    <measurement group_id="O5" value="27.0" lower_limit="11.9" upper_limit="61.0"/>
                    <measurement group_id="O6" value="7.5" lower_limit="4.0" upper_limit="14.0"/>
                    <measurement group_id="O7" value="20.0" lower_limit="10.8" upper_limit="37.0"/>
                    <measurement group_id="O8" value="5">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="924.9" lower_limit="289.1" upper_limit="2959.4"/>
                    <measurement group_id="O2" value="691.2" lower_limit="175.7" upper_limit="2720.1"/>
                    <measurement group_id="O3" value="452.5" lower_limit="124.5" upper_limit="1644.5"/>
                    <measurement group_id="O4" value="258.5" lower_limit="67.0" upper_limit="997.9"/>
                    <measurement group_id="O5" value="115.0" lower_limit="45.4" upper_limit="291.1"/>
                    <measurement group_id="O6" value="12.8" lower_limit="4.8" upper_limit="34.2"/>
                    <measurement group_id="O7" value="248.7" lower_limit="103.4" upper_limit="597.9"/>
                    <measurement group_id="O8" value="5.7" lower_limit="4.2" upper_limit="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1399.4" lower_limit="704.8" upper_limit="2778.8"/>
                    <measurement group_id="O2" value="244.9" lower_limit="50.1" upper_limit="1197.1"/>
                    <measurement group_id="O3" value="714.0" lower_limit="247.9" upper_limit="2056.8"/>
                    <measurement group_id="O4" value="396.1" lower_limit="98.3" upper_limit="1595.4"/>
                    <measurement group_id="O5" value="280.4" lower_limit="135.1" upper_limit="582.2"/>
                    <measurement group_id="O6" value="13.0" lower_limit="5.0" upper_limit="33.9"/>
                    <measurement group_id="O7" value="219.3" lower_limit="106.7" upper_limit="450.7"/>
                    <measurement group_id="O8" value="5.4" lower_limit="4.6" upper_limit="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="515.4" lower_limit="140.6" upper_limit="1888.5"/>
                    <measurement group_id="O2" value="403.2" lower_limit="96.0" upper_limit="1692.5"/>
                    <measurement group_id="O3" value="154.3" lower_limit="36.7" upper_limit="649.1"/>
                    <measurement group_id="O4" value="303.4" lower_limit="70.9" upper_limit="1297.4"/>
                    <measurement group_id="O5" value="65.6" lower_limit="21.2" upper_limit="203.0"/>
                    <measurement group_id="O6" value="8.8" lower_limit="4.5" upper_limit="17.5"/>
                    <measurement group_id="O7" value="104.6" lower_limit="37.7" upper_limit="289.8"/>
                    <measurement group_id="O8" value="8.1" lower_limit="2.7" upper_limit="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.0" lower_limit="40.5" upper_limit="277.3"/>
                    <measurement group_id="O2" value="48.5" lower_limit="13.1" upper_limit="180.2"/>
                    <measurement group_id="O3" value="66.7" lower_limit="22.5" upper_limit="197.2"/>
                    <measurement group_id="O4" value="93.9" lower_limit="29.0" upper_limit="303.8"/>
                    <measurement group_id="O5" value="24.4" lower_limit="10.8" upper_limit="55.2"/>
                    <measurement group_id="O6" value="8.5" lower_limit="4.7" upper_limit="15.2"/>
                    <measurement group_id="O7" value="26.6" lower_limit="12.3" upper_limit="57.3"/>
                    <measurement group_id="O8" value="5.7" lower_limit="4.2" upper_limit="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="718.4" lower_limit="239.3" upper_limit="2156.7"/>
                    <measurement group_id="O2" value="905.1" lower_limit="243.2" upper_limit="3368.4"/>
                    <measurement group_id="O3" value="508.0" lower_limit="137.6" upper_limit="1874.9"/>
                    <measurement group_id="O4" value="219.3" lower_limit="41.2" upper_limit="1165.6"/>
                    <measurement group_id="O5" value="92.8" lower_limit="36.5" upper_limit="236.2"/>
                    <measurement group_id="O6" value="12.8" lower_limit="4.8" upper_limit="34.2"/>
                    <measurement group_id="O7" value="149.8" lower_limit="63.9" upper_limit="351.1"/>
                    <measurement group_id="O8" value="6.3" lower_limit="3.7" upper_limit="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="702.0" lower_limit="403.1" upper_limit="1222.4"/>
                    <measurement group_id="O2" value="146.7" lower_limit="27.3" upper_limit="787.7"/>
                    <measurement group_id="O3" value="615.8" lower_limit="277.5" upper_limit="1366.8"/>
                    <measurement group_id="O4" value="256.7" lower_limit="61.0" upper_limit="1079.3"/>
                    <measurement group_id="O5" value="160.0" lower_limit="76.5" upper_limit="334.8"/>
                    <measurement group_id="O6" value="12.8" lower_limit="5.2" upper_limit="31.7"/>
                    <measurement group_id="O7" value="118.9" lower_limit="57.0" upper_limit="248.0"/>
                    <measurement group_id="O8" value="5.0">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="291.8" lower_limit="82.5" upper_limit="1032.3"/>
                    <measurement group_id="O2" value="472.6" lower_limit="84.6" upper_limit="2641.0"/>
                    <measurement group_id="O3" value="201.6" lower_limit="54.6" upper_limit="744.0"/>
                    <measurement group_id="O4" value="264.9" lower_limit="53.4" upper_limit="1313.1"/>
                    <measurement group_id="O5" value="70.1" lower_limit="27.6" upper_limit="178.4"/>
                    <measurement group_id="O6" value="9.6" lower_limit="4.6" upper_limit="20.1"/>
                    <measurement group_id="O7" value="80.0" lower_limit="31.9" upper_limit="200.7"/>
                    <measurement group_id="O8" value="9.3" lower_limit="2.2" upper_limit="38.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.9" lower_limit="30.9" upper_limit="216.9"/>
                    <measurement group_id="O2" value="80.0" lower_limit="17.5" upper_limit="364.8"/>
                    <measurement group_id="O3" value="61.1" lower_limit="21.7" upper_limit="172.3"/>
                    <measurement group_id="O4" value="80.0" lower_limit="18.9" upper_limit="338.6"/>
                    <measurement group_id="O5" value="17.5" lower_limit="8.4" upper_limit="36.6"/>
                    <measurement group_id="O6" value="7.2" lower_limit="4.2" upper_limit="12.3"/>
                    <measurement group_id="O7" value="17.0" lower_limit="8.6" upper_limit="33.3"/>
                    <measurement group_id="O8" value="5.4" lower_limit="4.5" upper_limit="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Fold Rise (GMFR) of Dengue Neutralizing Antibody Titers for Each of the 4 Dengue Serotypes</title>
        <time_frame>Day 28 and Day 90 (Parts 1 and 2) and Days 120, 180, 360, 720 and 1080 in Part 1</time_frame>
        <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Fold Rise (GMFR) of Dengue Neutralizing Antibody Titers for Each of the 4 Dengue Serotypes</title>
          <population>FAS included all randomized participants who received at least one dose of study vaccine or placebo and for whom valid pre-dosing and at least one valid post-dosing blood sample have been received.</population>
          <units>fold rise</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" lower_limit="1.61" upper_limit="7.24"/>
                    <measurement group_id="O2" value="0.90" lower_limit="0.57" upper_limit="1.41"/>
                    <measurement group_id="O3" value="8.93" lower_limit="3.61" upper_limit="22.09"/>
                    <measurement group_id="O4" value="1.03" lower_limit="0.67" upper_limit="1.56"/>
                    <measurement group_id="O5" value="29.47" lower_limit="11.70" upper_limit="74.22"/>
                    <measurement group_id="O6" value="1.00" lower_limit="0.88" upper_limit="1.13"/>
                    <measurement group_id="O7" value="27.94" lower_limit="13.64" upper_limit="57.23"/>
                    <measurement group_id="O8" value="1.05" lower_limit="0.94" upper_limit="1.18"/>
                    <measurement group_id="O9" value="27.58" lower_limit="20.91" upper_limit="36.38"/>
                    <measurement group_id="O10" value="0.97" lower_limit="0.82" upper_limit="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.89" lower_limit="2.01" upper_limit="31.00"/>
                    <measurement group_id="O2" value="0.71" lower_limit="0.45" upper_limit="1.11"/>
                    <measurement group_id="O3" value="20.26" lower_limit="5.34" upper_limit="76.93"/>
                    <measurement group_id="O4" value="1.05" lower_limit="0.69" upper_limit="1.59"/>
                    <measurement group_id="O5" value="181.02" lower_limit="47.86" upper_limit="684.60"/>
                    <measurement group_id="O6" value="1.39" lower_limit="0.81" upper_limit="2.37"/>
                    <measurement group_id="O7" value="128.00" lower_limit="44.62" upper_limit="367.22"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the lower limit of detection (LLOD).</measurement>
                    <measurement group_id="O9" value="113.02" lower_limit="0.1" upper_limit="8192.0"/>
                    <measurement group_id="O10" value="0.94" lower_limit="0.0" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.34" lower_limit="1.22" upper_limit="4.52"/>
                    <measurement group_id="O2" value="0.97" lower_limit="0.74" upper_limit="1.28"/>
                    <measurement group_id="O3" value="4.40" lower_limit="1.85" upper_limit="10.48"/>
                    <measurement group_id="O4" value="1.08" lower_limit="0.71" upper_limit="1.63"/>
                    <measurement group_id="O5" value="24.17" lower_limit="10.16" upper_limit="57.49"/>
                    <measurement group_id="O6" value="1.02" lower_limit="0.98" upper_limit="1.07"/>
                    <measurement group_id="O7" value="13.76" lower_limit="6.01" upper_limit="31.50"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="12.47" lower_limit="9.18" upper_limit="16.92"/>
                    <measurement group_id="O10" value="0.82" lower_limit="0.71" upper_limit="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="158"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.71" lower_limit="0.88" upper_limit="3.31"/>
                    <measurement group_id="O2" value="1.11" lower_limit="0.65" upper_limit="1.90"/>
                    <measurement group_id="O3" value="2.74" lower_limit="1.11" upper_limit="6.80"/>
                    <measurement group_id="O4" value="0.82" lower_limit="0.53" upper_limit="1.26"/>
                    <measurement group_id="O5" value="7.49" lower_limit="3.60" upper_limit="15.58"/>
                    <measurement group_id="O6" value="1.13" lower_limit="0.94" upper_limit="1.36"/>
                    <measurement group_id="O7" value="4.00" lower_limit="1.85" upper_limit="8.66"/>
                    <measurement group_id="O8" value="0.95" lower_limit="0.84" upper_limit="1.06"/>
                    <measurement group_id="O9" value="74.1" lower_limit="66.5" upper_limit="80.7"/>
                    <measurement group_id="O10" value="35.8" lower_limit="23.1" upper_limit="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.10" lower_limit="1.26" upper_limit="7.59"/>
                    <measurement group_id="O2" value="1.70" lower_limit="0.75" upper_limit="3.90"/>
                    <measurement group_id="O3" value="5.40" lower_limit="2.50" upper_limit="11.63"/>
                    <measurement group_id="O4" value="1.08" lower_limit="0.71" upper_limit="1.63"/>
                    <measurement group_id="O5" value="18.87" lower_limit="7.61" upper_limit="46.81"/>
                    <measurement group_id="O6" value="0.96" lower_limit="0.88" upper_limit="1.05"/>
                    <measurement group_id="O7" value="11.14" lower_limit="5.37" upper_limit="23.09"/>
                    <measurement group_id="O8" value="1.000">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="324.2" lower_limit="239.1" upper_limit="439.6"/>
                    <measurement group_id="O10" value="27.9" lower_limit="14.6" upper_limit="53.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.09" lower_limit="2.20" upper_limit="22.83"/>
                    <measurement group_id="O2" value="1.27" lower_limit="0.78" upper_limit="2.08"/>
                    <measurement group_id="O3" value="13.45" lower_limit="4.52" upper_limit="40.08"/>
                    <measurement group_id="O4" value="1.16" lower_limit="0.74" upper_limit="1.83"/>
                    <measurement group_id="O5" value="74.25" lower_limit="30.35" upper_limit="181.64"/>
                    <measurement group_id="O6" value="1.00" lower_limit="0.88" upper_limit="1.13"/>
                    <measurement group_id="O7" value="51.33" lower_limit="20.33" upper_limit="129.62"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="463.5" lower_limit="364.0" upper_limit="590.2"/>
                    <measurement group_id="O10" value="15.2" lower_limit="8.9" upper_limit="25.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.29" lower_limit="1.29" upper_limit="4.05"/>
                    <measurement group_id="O2" value="1.17" lower_limit="0.74" upper_limit="1.85"/>
                    <measurement group_id="O3" value="2.57" lower_limit="1.14" upper_limit="5.80"/>
                    <measurement group_id="O4" value="1.19" lower_limit="0.67" upper_limit="2.13"/>
                    <measurement group_id="O5" value="14.98" lower_limit="6.11" upper_limit="36.75"/>
                    <measurement group_id="O6" value="1.02" lower_limit="0.92" upper_limit="1.13"/>
                    <measurement group_id="O7" value="6.83" lower_limit="3.13" upper_limit="14.93"/>
                    <measurement group_id="O8" value="1.07" lower_limit="0.93" upper_limit="1.23"/>
                    <measurement group_id="O9" value="139.5" lower_limit="99.7" upper_limit="195.1"/>
                    <measurement group_id="O10" value="17.1" lower_limit="10.2" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 90, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="159"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" lower_limit="1.02" upper_limit="2.66"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.52" upper_limit="1.01"/>
                    <measurement group_id="O3" value="3.70" lower_limit="1.78" upper_limit="7.66"/>
                    <measurement group_id="O4" value="1.22" lower_limit="0.72" upper_limit="2.07"/>
                    <measurement group_id="O5" value="3.81" lower_limit="1.73" upper_limit="8.36"/>
                    <measurement group_id="O6" value="1.18" lower_limit="0.90" upper_limit="1.54"/>
                    <measurement group_id="O7" value="2.45" lower_limit="1.39" upper_limit="4.32"/>
                    <measurement group_id="O8" value="1.00" lower_limit="0.81" upper_limit="1.23"/>
                    <measurement group_id="O9" value="33.7" lower_limit="25.4" upper_limit="44.7"/>
                    <measurement group_id="O10" value="11.8" lower_limit="8.2" upper_limit="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.64" lower_limit="1.09" upper_limit="12.10"/>
                    <measurement group_id="O2" value="0.81" lower_limit="0.56" upper_limit="1.16"/>
                    <measurement group_id="O3" value="12.63" lower_limit="5.56" upper_limit="28.70"/>
                    <measurement group_id="O4" value="0.82" lower_limit="0.34" upper_limit="2.01"/>
                    <measurement group_id="O5" value="42.36" lower_limit="19.57" upper_limit="91.70"/>
                    <measurement group_id="O6" value="1.23" lower_limit="0.72" upper_limit="2.09"/>
                    <measurement group_id="O7" value="39.27" lower_limit="24.12" upper_limit="63.94"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="35.44" lower_limit="26.46" upper_limit="47.48"/>
                    <measurement group_id="O10" value="1.01" lower_limit="0.79" upper_limit="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.79" lower_limit="2.81" upper_limit="27.47"/>
                    <measurement group_id="O2" value="1.08" lower_limit="0.79" upper_limit="1.49"/>
                    <measurement group_id="O3" value="20.59" lower_limit="6.45" upper_limit="65.66"/>
                    <measurement group_id="O4" value="1.00" lower_limit="0.67" upper_limit="1.50"/>
                    <measurement group_id="O5" value="75.48" lower_limit="29.82" upper_limit="191.08"/>
                    <measurement group_id="O6" value="1.73" lower_limit="0.56" upper_limit="5.38"/>
                    <measurement group_id="O7" value="50.53" lower_limit="24.11" upper_limit="105.89"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="44.16" lower_limit="33.51" upper_limit="58.20"/>
                    <measurement group_id="O10" value="0.92" lower_limit="0.67" upper_limit="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.78" lower_limit="1.44" upper_limit="5.37"/>
                    <measurement group_id="O2" value="1.24" lower_limit="0.70" upper_limit="2.20"/>
                    <measurement group_id="O3" value="4.54" lower_limit="2.02" upper_limit="10.17"/>
                    <measurement group_id="O4" value="1.03" lower_limit="0.60" upper_limit="1.75"/>
                    <measurement group_id="O5" value="28.98" lower_limit="14.52" upper_limit="57.87"/>
                    <measurement group_id="O6" value="1.73" lower_limit="0.73" upper_limit="4.14"/>
                    <measurement group_id="O7" value="20.26" lower_limit="12.02" upper_limit="34.17"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                    <measurement group_id="O9" value="19.20" lower_limit="14.75" upper_limit="24.98"/>
                    <measurement group_id="O10" value="0.80" lower_limit="0.64" upper_limit="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 120, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="22"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="156"/>
                    <count group_id="O10" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.45" lower_limit="1.44" upper_limit="4.19"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.43" upper_limit="1.23"/>
                    <measurement group_id="O3" value="4.00" lower_limit="2.00" upper_limit="8.00"/>
                    <measurement group_id="O4" value="1.22" lower_limit="0.72" upper_limit="2.07"/>
                    <measurement group_id="O5" value="7.87" lower_limit="4.25" upper_limit="14.57"/>
                    <measurement group_id="O6" value="2.17" lower_limit="0.99" upper_limit="4.76"/>
                    <measurement group_id="O7" value="6.02" lower_limit="3.81" upper_limit="9.53"/>
                    <measurement group_id="O8" value="0.94" lower_limit="0.82" upper_limit="1.08"/>
                    <measurement group_id="O9" value="7.43" lower_limit="5.96" upper_limit="9.27"/>
                    <measurement group_id="O10" value="1.03" lower_limit="0.91" upper_limit="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.94" lower_limit="1.35" upper_limit="11.54"/>
                    <measurement group_id="O2" value="0.89" lower_limit="0.59" upper_limit="1.35"/>
                    <measurement group_id="O3" value="9.16" lower_limit="2.89" upper_limit="29.05"/>
                    <measurement group_id="O4" value="0.71" lower_limit="0.45" upper_limit="1.10"/>
                    <measurement group_id="O5" value="17.70" lower_limit="10.04" upper_limit="31.22"/>
                    <measurement group_id="O6" value="1.13" lower_limit="0.77" upper_limit="1.66"/>
                    <measurement group_id="O7" value="16.81" lower_limit="9.56" upper_limit="29.53"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.53" lower_limit="3.61" upper_limit="36.83"/>
                    <measurement group_id="O2" value="0.94" lower_limit="0.55" upper_limit="1.63"/>
                    <measurement group_id="O3" value="17.16" lower_limit="5.15" upper_limit="57.17"/>
                    <measurement group_id="O4" value="1.03" lower_limit="0.58" upper_limit="1.84"/>
                    <measurement group_id="O5" value="49.34" lower_limit="22.02" upper_limit="110.57"/>
                    <measurement group_id="O6" value="1.44" lower_limit="0.66" upper_limit="3.17"/>
                    <measurement group_id="O7" value="43.89" lower_limit="21.22" upper_limit="90.80"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.42" lower_limit="1.23" upper_limit="4.76"/>
                    <measurement group_id="O2" value="1.26" lower_limit="0.95" upper_limit="1.68"/>
                    <measurement group_id="O3" value="4.58" lower_limit="1.72" upper_limit="12.21"/>
                    <measurement group_id="O4" value="0.73" lower_limit="0.44" upper_limit="1.20"/>
                    <measurement group_id="O5" value="14.52" lower_limit="7.70" upper_limit="27.38"/>
                    <measurement group_id="O6" value="1.50" lower_limit="0.86" upper_limit="2.64"/>
                    <measurement group_id="O7" value="9.66" lower_limit="4.84" upper_limit="19.30"/>
                    <measurement group_id="O8" value="1.21" lower_limit="0.79" upper_limit="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 180, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="14"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.38" lower_limit="1.43" upper_limit="3.95"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.63" upper_limit="1.58"/>
                    <measurement group_id="O3" value="3.35" lower_limit="1.60" upper_limit="7.01"/>
                    <measurement group_id="O4" value="0.91" lower_limit="0.60" upper_limit="1.37"/>
                    <measurement group_id="O5" value="5.76" lower_limit="3.14" upper_limit="10.55"/>
                    <measurement group_id="O6" value="1.44" lower_limit="0.88" upper_limit="2.36"/>
                    <measurement group_id="O7" value="4.13" lower_limit="2.29" upper_limit="7.43"/>
                    <measurement group_id="O8" value="0.94" lower_limit="0.82" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.51" lower_limit="2.13" upper_limit="14.26"/>
                    <measurement group_id="O2" value="0.67" lower_limit="0.47" upper_limit="0.95"/>
                    <measurement group_id="O3" value="6.17" lower_limit="2.36" upper_limit="16.14"/>
                    <measurement group_id="O4" value="1.09" lower_limit="0.50" upper_limit="2.37"/>
                    <measurement group_id="O5" value="10.14" lower_limit="4.81" upper_limit="21.39"/>
                    <measurement group_id="O6" value="1.39" lower_limit="0.91" upper_limit="2.12"/>
                    <measurement group_id="O7" value="14.90" lower_limit="7.48" upper_limit="29.66"/>
                    <measurement group_id="O8" value="1.07" lower_limit="0.93" upper_limit="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.04" lower_limit="2.76" upper_limit="29.60"/>
                    <measurement group_id="O2" value="0.93" lower_limit="0.64" upper_limit="1.34"/>
                    <measurement group_id="O3" value="9.65" lower_limit="3.34" upper_limit="27.83"/>
                    <measurement group_id="O4" value="1.16" lower_limit="0.54" upper_limit="2.46"/>
                    <measurement group_id="O5" value="25.30" lower_limit="10.10" upper_limit="63.38"/>
                    <measurement group_id="O6" value="1.71" lower_limit="0.81" upper_limit="3.59"/>
                    <measurement group_id="O7" value="32.84" lower_limit="15.76" upper_limit="68.42"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.56" lower_limit="1.21" upper_limit="5.39"/>
                    <measurement group_id="O2" value="0.95" lower_limit="0.71" upper_limit="1.27"/>
                    <measurement group_id="O3" value="2.44" lower_limit="1.00" upper_limit="5.96"/>
                    <measurement group_id="O4" value="0.83" lower_limit="0.44" upper_limit="1.57"/>
                    <measurement group_id="O5" value="7.92" lower_limit="3.28" upper_limit="19.10"/>
                    <measurement group_id="O6" value="1.41" lower_limit="0.88" upper_limit="2.29"/>
                    <measurement group_id="O7" value="9.28" lower_limit="4.55" upper_limit="18.92"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 360, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="21"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" lower_limit="1.15" upper_limit="4.70"/>
                    <measurement group_id="O2" value="0.75" lower_limit="0.53" upper_limit="1.06"/>
                    <measurement group_id="O3" value="3.45" lower_limit="1.66" upper_limit="7.17"/>
                    <measurement group_id="O4" value="1.03" lower_limit="0.45" upper_limit="2.38"/>
                    <measurement group_id="O5" value="3.29" lower_limit="1.83" upper_limit="5.89"/>
                    <measurement group_id="O6" value="1.18" lower_limit="0.96" upper_limit="1.44"/>
                    <measurement group_id="O7" value="2.92" lower_limit="1.71" upper_limit="4.98"/>
                    <measurement group_id="O8" value="0.94" lower_limit="0.82" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.65" lower_limit="1.45" upper_limit="14.97"/>
                    <measurement group_id="O2" value="0.63" lower_limit="0.43" upper_limit="0.92"/>
                    <measurement group_id="O3" value="3.65" lower_limit="1.68" upper_limit="7.96"/>
                    <measurement group_id="O4" value="1.27" lower_limit="0.64" upper_limit="2.54"/>
                    <measurement group_id="O5" value="8.83" lower_limit="4.69" upper_limit="16.64"/>
                    <measurement group_id="O6" value="1.13" lower_limit="0.87" upper_limit="1.46"/>
                    <measurement group_id="O7" value="16.77" lower_limit="7.12" upper_limit="39.51"/>
                    <measurement group_id="O8" value="1.15" lower_limit="0.84" upper_limit="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.13" lower_limit="2.52" upper_limit="33.07"/>
                    <measurement group_id="O2" value="0.80" lower_limit="0.51" upper_limit="1.24"/>
                    <measurement group_id="O3" value="8.61" lower_limit="3.28" upper_limit="22.56"/>
                    <measurement group_id="O4" value="0.88" lower_limit="0.52" upper_limit="1.48"/>
                    <measurement group_id="O5" value="21.53" lower_limit="9.91" upper_limit="46.81"/>
                    <measurement group_id="O6" value="1.30" lower_limit="0.73" upper_limit="2.32"/>
                    <measurement group_id="O7" value="24.10" lower_limit="11.73" upper_limit="49.52"/>
                    <measurement group_id="O8" value="1.07" lower_limit="0.92" upper_limit="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.15" lower_limit="1.38" upper_limit="7.21"/>
                    <measurement group_id="O2" value="0.93" lower_limit="0.67" upper_limit="1.28"/>
                    <measurement group_id="O3" value="2.00" lower_limit="0.76" upper_limit="5.28"/>
                    <measurement group_id="O4" value="1.21" lower_limit="0.72" upper_limit="2.02"/>
                    <measurement group_id="O5" value="5.04" lower_limit="2.21" upper_limit="11.50"/>
                    <measurement group_id="O6" value="1.06" lower_limit="0.80" upper_limit="1.41"/>
                    <measurement group_id="O7" value="10.79" lower_limit="4.16" upper_limit="28.00"/>
                    <measurement group_id="O8" value="1.62" lower_limit="0.54" upper_limit="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 720, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="9"/>
                    <count group_id="O3" value="19"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" lower_limit="0.77" upper_limit="3.10"/>
                    <measurement group_id="O2" value="0.56" lower_limit="0.39" upper_limit="0.82"/>
                    <measurement group_id="O3" value="2.88" lower_limit="1.41" upper_limit="5.90"/>
                    <measurement group_id="O4" value="1.62" lower_limit="0.76" upper_limit="3.43"/>
                    <measurement group_id="O5" value="2.97" lower_limit="1.56" upper_limit="5.66"/>
                    <measurement group_id="O6" value="1.33" lower_limit="0.95" upper_limit="1.86"/>
                    <measurement group_id="O7" value="3.88" lower_limit="1.89" upper_limit="7.96"/>
                    <measurement group_id="O8" value="1.07" lower_limit="0.74" upper_limit="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.91" lower_limit="1.40" upper_limit="10.94"/>
                    <measurement group_id="O2" value="0.77" lower_limit="0.45" upper_limit="1.31"/>
                    <measurement group_id="O3" value="3.43" lower_limit="1.66" upper_limit="7.08"/>
                    <measurement group_id="O4" value="1.33" lower_limit="0.73" upper_limit="2.41"/>
                    <measurement group_id="O5" value="7.13" lower_limit="3.86" upper_limit="13.17"/>
                    <measurement group_id="O6" value="1.13" lower_limit="0.79" upper_limit="1.62"/>
                    <measurement group_id="O7" value="9.59" lower_limit="4.72" upper_limit="19.48"/>
                    <measurement group_id="O8" value="1.26" lower_limit="0.74" upper_limit="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.59" lower_limit="1.45" upper_limit="14.59"/>
                    <measurement group_id="O2" value="0.68" lower_limit="0.51" upper_limit="0.90"/>
                    <measurement group_id="O3" value="6.35" lower_limit="2.54" upper_limit="15.87"/>
                    <measurement group_id="O4" value="0.83" lower_limit="0.51" upper_limit="1.34"/>
                    <measurement group_id="O5" value="12.29" lower_limit="5.76" upper_limit="26.22"/>
                    <measurement group_id="O6" value="1.28" lower_limit="0.73" upper_limit="2.24"/>
                    <measurement group_id="O7" value="12.70" lower_limit="5.92" upper_limit="27.25"/>
                    <measurement group_id="O8" value="1.00">Lower and upper limits of CI could not be evaluated as titers were below the LLOD.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.87" lower_limit="0.98" upper_limit="3.54"/>
                    <measurement group_id="O2" value="1.04" lower_limit="0.75" upper_limit="1.45"/>
                    <measurement group_id="O3" value="2.33" lower_limit="0.97" upper_limit="5.59"/>
                    <measurement group_id="O4" value="1.17" lower_limit="0.65" upper_limit="2.10"/>
                    <measurement group_id="O5" value="5.38" lower_limit="2.71" upper_limit="10.71"/>
                    <measurement group_id="O6" value="1.15" lower_limit="0.89" upper_limit="1.50"/>
                    <measurement group_id="O7" value="8.55" lower_limit="3.97" upper_limit="18.38"/>
                    <measurement group_id="O8" value="1.85" lower_limit="0.45" upper_limit="7.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1080, TDV-4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="18"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="17"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="9"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" lower_limit="0.71" upper_limit="1.87"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.58" upper_limit="1.71"/>
                    <measurement group_id="O3" value="2.42" lower_limit="1.18" upper_limit="4.98"/>
                    <measurement group_id="O4" value="1.46" lower_limit="0.66" upper_limit="3.21"/>
                    <measurement group_id="O5" value="2.14" lower_limit="1.23" upper_limit="3.72"/>
                    <measurement group_id="O6" value="1.13" lower_limit="0.94" upper_limit="1.36"/>
                    <measurement group_id="O7" value="2.44" lower_limit="1.40" upper_limit="4.25"/>
                    <measurement group_id="O8" value="1.00" lower_limit="0.77" upper_limit="1.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Confirmed Dengue Fever</title>
        <description>Dengue fever was assessed in participants who had 3 consecutive days of fever &gt;38Â°C and tested positive for dengue virus by polymerase chain reaction (PCR) analysis.</description>
        <time_frame>Day 1 to Day 1080</time_frame>
        <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Part I: TDV 21 to 45 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O2">
            <title>Part I: Placebo 21 to 45 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
          </group>
          <group group_id="O3">
            <title>Part I: TDV 12 to 20 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O4">
            <title>Part I: Placebo 12 to 20 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
          </group>
          <group group_id="O5">
            <title>Part I: TDV 6 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O6">
            <title>Part I: Placebo 6 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
          </group>
          <group group_id="O7">
            <title>Part I: TDV 1.5 to 5 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O8">
            <title>Part I: Placebo 1.5 to 5 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
          <group group_id="O9">
            <title>Part II: TDV 1.5 to 11 Years</title>
            <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
          </group>
          <group group_id="O10">
            <title>Part II: Placebo 1.5 to 11 Years</title>
            <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Confirmed Dengue Fever</title>
          <description>Dengue fever was assessed in participants who had 3 consecutive days of fever &gt;38Â°C and tested positive for dengue virus by polymerase chain reaction (PCR) analysis.</description>
          <population>The safety set included all randomized participants who received at least one dose of study vaccine (or placebo).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="14"/>
                <count group_id="O5" value="21"/>
                <count group_id="O6" value="17"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="13"/>
                <count group_id="O9" value="159"/>
                <count group_id="O10" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious AEs were collected throughout the study Day 0 up to Day 1080. Other (non-serious) AEs were collected within 28 days of all vaccinations (up to Day 28 and Day 118).</time_frame>
      <desc>At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Part I: TDV 21 to 45 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 plaque forming units (PFU), 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="E2">
          <title>Part I: Placebo 21 to 45 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 21 to 45 years.</description>
        </group>
        <group group_id="E3">
          <title>Part I: TDV 12 to 20 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="E4">
          <title>Part I: Placebo 12 to 20 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 12 to 20 years.</description>
        </group>
        <group group_id="E5">
          <title>Part I: TDV 6 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="E6">
          <title>Part I: Placebo 6 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 6 to 11 years.</description>
        </group>
        <group group_id="E7">
          <title>Part I: TDV 1.5 to 5 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="E8">
          <title>Part I: Placebo 1.5 to 5 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
        <group group_id="E9">
          <title>Part II: TDV 1.5 to 11 Years</title>
          <description>TDV 0.5 mL, injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 11 years. TDV comprised of 4 recombinant, live attenuated dengue virus strains: TDV-1, TDV-2, TDV-3 and TDV-4 containing 2*10^4 PFU, 5*10^4 PFU, 1*10^5 PFU, and 3*10^5 PFU respectively, total virus per dose: 4.7*10^5 PFU.</description>
        </group>
        <group group_id="E10">
          <title>Part II: Placebo 1.5 to 11 Years</title>
          <description>TDV placebo-matching 0.5 mL injection, subcutaneously, once on Day 0 (first dose) and Day 90 (second dose) in participants aged 1.5 to 5 years.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (14.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="14" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Hand-foot-and-mouth disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Child maltreatment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Skull fractured base</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Tonsillar hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (14.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="14" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="12" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="87" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="30" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="16" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="32" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="14" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Viral rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="13" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Urticaria papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="17"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Takeda</organization>
      <phone>+1-877-825-3327</phone>
      <email>trialdisclosures@takeda.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

